Abcm Corporation (ABCM) News
Filter ABCM News Items
ABCM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ABCM News Highlights
- For ABCM, its 30 day story count is now at 5.
- Over the past 19 days, the trend for ABCM's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about ABCM are AGM, MATH and SEAT.
Latest ABCM News From Around the Web
Below are the latest news stories about ABCAM PLC that investors may wish to consider to help them evaluate ABCM as an investment opportunity.
ABCAM PLC: Statement on calling an Extraordinary General MeetingAbcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting (the "EGM"). The Company is reviewing the notice with its legal advisors and will provide a further update in due course. Shareholders do not need to take any action at this time. |
How Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55%The mean of analysts' price targets for Abcam PLC Sponsored ADR (ABCM) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
ABCAM PLC Result of Annual General MeetingAbcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces the voting results from the Annual General Meeting (the "AGM") held today. A total of 196,862,506 shares representing 85.7% of Abcam's issued and outstanding voting capital (including withheld) were voted in connection with the meeting. |
Abcam Founder Ramps Up Board Seat Push at $4 Billion Biotech(Bloomberg) -- UK entrepreneur Jonathan Milner is ramping up pressure on Abcam Plc to give him a board seat, as he seeks to improve performance at the biotechnology supplier he started 25 years ago. Most Read from BloombergElon Musk Says He’s Stepping Down as Twitter’s CEOKen Griffin’s Hand-Picked Math Prodigy Runs Market-Making EmpireJamie Dimon Says US Needs to 'Finish' the Bank CrisisFlorida’s Money Man Threatens to Cut Ties With Bank of America, Wells FargoTurkey Markets Rally as Candidate W |
Abcam Founder Pushes for Better Performance at Biotech(Bloomberg) -- Abcam Plc founder Jonathan Milner is pushing for better performance at the biotechnology supplier he started 25 years ago.Most Read from BloombergJamie Dimon Says US Needs to 'Finish' the Bank CrisisTurkey Markets Rally as Candidate Withdraws Days Before VoteHedge Funds Drive Credit Suisse CDS Higher on Bets of a PayoutFamily Builds $900 Million Brazil Farming Empire After 935% GainSteve Schwarzman Holds Off Giving Money to DeSantis After Meeting HimThe British scientist and entre |
Abcam, plc Business UpdateAbcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following updates. |
ABCAM PLC Comments on Investor EngagementAbcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, notes the Form 13D filed today by founder and former director Dr Jonathan Milner and related press reports. |
ABCAM PLC: Upcoming Abcam Investor EventsAbcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the following investor events. |
ABCAM PLC: Trading UpdateAbcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the quarter ending 31 March 2023. |
Abcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General MeetingAbcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 20 March 2023 of its final results for the year ended 31 December 2022 on Form 20-F with the Securities and Exchange Commission, the Abcam plc Annual Report and Accounts 2022 (the "Annual Report") have been published today and are available on the Abcam plc website at corporate.abcam.com |